| Dr Klarissa N Beller, MD | |
|
1200 Hilyard St Ste 520a, Eugene, OR 97401-8122 | |
| (541) 687-6041 | |
| (541) 687-6009 |
| Full Name | Dr Klarissa N Beller |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 22 Years |
| Location | 1200 Hilyard St Ste 520a, Eugene, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104898956 | NPI | - | NPPES |
| 286635 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | MD23800 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Marcus Daly Memorial Hospital - Cah | Hamilton, MT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Marcus Daly Memorial Hospital Corporation | 5597664474 | 90 |
News Archive
Bruker announced today at the 2012 Materials Research Society (MRS) Fall Meeting the release of a new line of IRIS TERS Probes. By enabling Tip-Enhanced Raman Spectroscopy (TERS), the new IRIS TERS probe tips provide users a complete path to non-destructive, label-free chemical detection at the nanoscale.
Autophagy, the process by which cells that are starved for food resort to chewing up their own damaged proteins and membranes and recycling them into fuel, has emerged as a key pathway that cancer cells use to survive in the face of assault by chemotherapy and radiation.
Genticel, a clinical-stage biotechnology company and developer of innovative immunotherapies to prevent cancers caused by the human papillomavirus, today announces that the independent Data Safety Monitoring Board recommends the continuation, per protocol, of its phase 2 clinical trial of GTL001 in patients infected with HPV 16 and/or 18, the two HPV types responsible for 70% of cervical cancer cases.
"Data presented from the FEM-PrEP trial by Dr. Lut Van Damme Tuesday at the 19th Conference on Retroviruses and Opportunistic Infections in Seattle highlighted the challenge that adherence plays in successfully deploying effective Pre-Exposure Prophylaxis (PrEP) interventions," HIV Medicine Association Executive Director Andrea Weddle writes in this guest post in the Center for Global Health Policy's "Science Speaks" blog.
› Verified 4 days ago
| Entity Name | Marcus Daly Memorial Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659475846 PECOS PAC ID: 5597664474 Enrollment ID: O20040202001033 |
News Archive
Bruker announced today at the 2012 Materials Research Society (MRS) Fall Meeting the release of a new line of IRIS TERS Probes. By enabling Tip-Enhanced Raman Spectroscopy (TERS), the new IRIS TERS probe tips provide users a complete path to non-destructive, label-free chemical detection at the nanoscale.
Autophagy, the process by which cells that are starved for food resort to chewing up their own damaged proteins and membranes and recycling them into fuel, has emerged as a key pathway that cancer cells use to survive in the face of assault by chemotherapy and radiation.
Genticel, a clinical-stage biotechnology company and developer of innovative immunotherapies to prevent cancers caused by the human papillomavirus, today announces that the independent Data Safety Monitoring Board recommends the continuation, per protocol, of its phase 2 clinical trial of GTL001 in patients infected with HPV 16 and/or 18, the two HPV types responsible for 70% of cervical cancer cases.
"Data presented from the FEM-PrEP trial by Dr. Lut Van Damme Tuesday at the 19th Conference on Retroviruses and Opportunistic Infections in Seattle highlighted the challenge that adherence plays in successfully deploying effective Pre-Exposure Prophylaxis (PrEP) interventions," HIV Medicine Association Executive Director Andrea Weddle writes in this guest post in the Center for Global Health Policy's "Science Speaks" blog.
› Verified 4 days ago
| Entity Name | Marcus Daly Memorial Hospital Corporation |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1659475846 PECOS PAC ID: 5597664474 Enrollment ID: O20061104000439 |
News Archive
Bruker announced today at the 2012 Materials Research Society (MRS) Fall Meeting the release of a new line of IRIS TERS Probes. By enabling Tip-Enhanced Raman Spectroscopy (TERS), the new IRIS TERS probe tips provide users a complete path to non-destructive, label-free chemical detection at the nanoscale.
Autophagy, the process by which cells that are starved for food resort to chewing up their own damaged proteins and membranes and recycling them into fuel, has emerged as a key pathway that cancer cells use to survive in the face of assault by chemotherapy and radiation.
Genticel, a clinical-stage biotechnology company and developer of innovative immunotherapies to prevent cancers caused by the human papillomavirus, today announces that the independent Data Safety Monitoring Board recommends the continuation, per protocol, of its phase 2 clinical trial of GTL001 in patients infected with HPV 16 and/or 18, the two HPV types responsible for 70% of cervical cancer cases.
"Data presented from the FEM-PrEP trial by Dr. Lut Van Damme Tuesday at the 19th Conference on Retroviruses and Opportunistic Infections in Seattle highlighted the challenge that adherence plays in successfully deploying effective Pre-Exposure Prophylaxis (PrEP) interventions," HIV Medicine Association Executive Director Andrea Weddle writes in this guest post in the Center for Global Health Policy's "Science Speaks" blog.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Klarissa N Beller, MD Po Box 24410, Eugene, OR 97402-0451 Ph: () - | Dr Klarissa N Beller, MD 1200 Hilyard St Ste 520a, Eugene, OR 97401-8122 Ph: (541) 687-6041 |
News Archive
Bruker announced today at the 2012 Materials Research Society (MRS) Fall Meeting the release of a new line of IRIS TERS Probes. By enabling Tip-Enhanced Raman Spectroscopy (TERS), the new IRIS TERS probe tips provide users a complete path to non-destructive, label-free chemical detection at the nanoscale.
Autophagy, the process by which cells that are starved for food resort to chewing up their own damaged proteins and membranes and recycling them into fuel, has emerged as a key pathway that cancer cells use to survive in the face of assault by chemotherapy and radiation.
Genticel, a clinical-stage biotechnology company and developer of innovative immunotherapies to prevent cancers caused by the human papillomavirus, today announces that the independent Data Safety Monitoring Board recommends the continuation, per protocol, of its phase 2 clinical trial of GTL001 in patients infected with HPV 16 and/or 18, the two HPV types responsible for 70% of cervical cancer cases.
"Data presented from the FEM-PrEP trial by Dr. Lut Van Damme Tuesday at the 19th Conference on Retroviruses and Opportunistic Infections in Seattle highlighted the challenge that adherence plays in successfully deploying effective Pre-Exposure Prophylaxis (PrEP) interventions," HIV Medicine Association Executive Director Andrea Weddle writes in this guest post in the Center for Global Health Policy's "Science Speaks" blog.
› Verified 4 days ago
Richard Romm, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 677 E 12th Ave, Suite N400, Eugene, OR 97401 Phone: 541-484-4332 Fax: 541-302-0786 | |
William E Wilkins Jr., M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 330 S Garden Way Ste 350, Eugene, OR 97401 Phone: 541-746-6816 | |
Dr. Norman Paul Hudson, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2479 Oakmont Way, Eugene, OR 97401 Phone: 541-484-0195 Fax: 541-343-6317 | |
Kirk Douglas Jacobson, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1488 Oak St, Eugene, OR 97401 Phone: 541-431-0000 Fax: 541-344-6176 | |
Matthew B. Walter, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3125 Chad Dr Ste 100, Eugene, OR 97408 Phone: 541-687-1712 Fax: 541-687-7943 | |
Sarah Cassell, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 132 E Broadway Ste 830, Eugene, OR 97401 Phone: 541-687-0816 Fax: 541-687-1086 |